alexa Histone Deacetylase Inhibitor for Neurodegenerative Diseases: A Possible Medicinal Strategy by Prevention of ER Stress-Mediated Apoptosis and Induction of Neurite Elongation | Abstract
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Histone Deacetylase Inhibitor for Neurodegenerative Diseases: A Possible Medicinal Strategy by Prevention of ER Stress-Mediated Apoptosis and Induction of Neurite Elongation

Koji Shimoke1,2*, Takuma Tomioka2, Kouta Okamoto2, Daichi Fujiki2, Shinichi Uesato1,2, Hitoshi Nakayama3 and Toshihiko Ikeuchi1,2
1Department of Life Science and Biotechnology, Faculty of Chemistry, Materials and Bioengineering, Kansai University, Japan
2Graduate School of Science and Engineering, Kansai University, Japan
3Department of Pharmacology, Nara Medical University, School of Medicine, Japan
Corresponding Author : Shimoke K
Laboratory of Neurobiology
Faculty of Chemistry, Materials and Bioengineering
Kansai University, 3-3-35 Yamate-cho
Suita, Osaka 564-8680, Japan
Tel: +81-6-6368-0853
Fax: +81-6-6330-3770
E-mail: [email protected]
Received February 06, 2013; Accepted March 02, 2013; Published March 04, 2013
Citation: Shimoke K, Tomioka T, Okamoto K, Fujiki D, Uesato S, Nakayama H, et al. (2013) Histone Deacetylase Inhibitor for Neurodegenerative Diseases: A Possible Medicinal Strategy by Prevention of ER Stress-Mediated Apoptosis and Induction of Neurite Elongation. Clin Pharmacol Biopharm S1:006. doi:10.4172/2167-065X.S1-006
Copyright: © 2013 Shimoke K, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Neurite outgrowth is primarily necessary step to construct a neuronal network. If this step is collapsed, neurons are died and neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases, which are known to induce endoplasmic reticulum (ER) stress-mediated apoptosis, are occurred.
It has been elucidating that histone deacetylase (HDAC) plays a crucial role in the silencing of gene expression by the specific mechanisms. Thus, HDAC inhibitors have been shown to induce specific genes. We reported the upregulation of the nur77 gene, followed by histone modification via the protein kinase A signaling pathway or HDAC inhibitor-mediated molecular mechanisms. Then, we also focused on neurite outgrowth as a functional neuronal marker, and then described molecular targets and progressive pharmaceutical care for neurodegenerative disorders by using K-350. We propose that this kind of the candidate compound might contribute to build the therapeutic strategy for neurodegenerative diseases.

Keywords

Recommended Conferences

33rd World Congress on Pharmacology

Barcelona, Spain
Share This Page
Top